130 related articles for article (PubMed ID: 35128825)
1. The metabolism of valerylfentanyl using human liver microsomes and zebrafish larvae.
Cooman T; Hoover B; Sauvé B; Bergeron SA; Quinete N; Gardinali P; Arroyo LE
Drug Test Anal; 2022 Jun; 14(6):1116-1129. PubMed ID: 35128825
[TBL] [Abstract][Full Text] [Related]
2. In vitro metabolism of the novel synthetic opioid agonist cyclopropylfentanyl and subsequent confirmation in authentic human samples using liquid chromatography-high resolution mass spectrometry.
Cutler C; Hudson S
Drug Test Anal; 2019 Aug; 11(8):1134-1143. PubMed ID: 31081594
[TBL] [Abstract][Full Text] [Related]
3. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.
Labroo RB; Paine MF; Thummel KE; Kharasch ED
Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623
[TBL] [Abstract][Full Text] [Related]
4. In vitro Characterization of NPS Metabolites Produced by Human Liver Microsomes and the HepaRG Cell Line Using Liquid Chromatographyhigh Resolution Mass Spectrometry (LC-HRMS) Analysis: Application to Furanyl Fentanyl.
Richeval C; Gicquel T; Hugbart C; Le Dare B; Allorge D; Morel I; Gaulier JM
Curr Pharm Biotechnol; 2017; 18(10):806-814. PubMed ID: 29173157
[TBL] [Abstract][Full Text] [Related]
5. Metabolite Profiling of Ortho-, Meta- and Para-Fluorofentanyl by Hepatocytes and High-Resolution Mass Spectrometry.
Gundersen POM; Åstrand A; Gréen H; Josefsson M; Spigset O; Vikingsson S
J Anal Toxicol; 2020 Mar; 44(2):140-148. PubMed ID: 31788682
[TBL] [Abstract][Full Text] [Related]
6. Binding preference at the μ-opioid receptor underlies distinct pharmacology of cyclopropyl versus valeryl analogs of fentanyl.
Xie B; Le Rouzic VP; Goldberg A; Tsai MM; Chen L; Zhang T; Sinha A; Pan YX; Baumann MH; Shi L
Neuropharmacology; 2023 Apr; 227():109442. PubMed ID: 36731721
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation of tritiated fentanyl in human liver microsomes. Monitoring metabolism using phenylacetic acid and 2-phenylethanol.
Tateishi T; Wood AJ; Guengerich FP; Wood M
Biochem Pharmacol; 1995 Nov; 50(11):1921-4. PubMed ID: 8615873
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profile determination of 2F-viminol - A novel synthetic opioid identified in forensic investigations.
Velez A; Papsun DM; Scott KS; Krotulski AJ
J Forensic Sci; 2023 Jan; 68(1):212-221. PubMed ID: 36372911
[TBL] [Abstract][Full Text] [Related]
9. Acute Intoxications Involving Valerylfentanyl Identified at the New York City Office of Chief Medical Examiner.
Walsh E; Forni A; Pardi J; Cooper G
J Anal Toxicol; 2021 Sep; 45(8):835-839. PubMed ID: 34110421
[TBL] [Abstract][Full Text] [Related]
10. Human metabolism and basic pharmacokinetic evaluation of AP-238: A recently emerged acylpiperazine opioid.
Brunetti P; Berardinelli D; Giorgetti A; Schwelm HM; Haschimi B; Pelotti S; Busardò FP; Auwärter V
Drug Test Anal; 2024 Feb; 16(2):221-235. PubMed ID: 37376716
[TBL] [Abstract][Full Text] [Related]
11. Determination of Fentanyl, Alpha-Methylfentanyl, Beta-Hydroxyfentanyl and the Metabolite Norfentanyl in Rat Urine by LC-MS-MS.
Li L; Yu X; Lyu L; Duan H; Chen Y; Bian J; Xu Z; Liu L; Zhang Y
J Anal Toxicol; 2022 Apr; 46(4):421-431. PubMed ID: 33647104
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry.
Feasel MG; Wohlfarth A; Nilles JM; Pang S; Kristovich RL; Huestis MA
AAPS J; 2016 Nov; 18(6):1489-1499. PubMed ID: 27495118
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of Fentanyl and Metabolites from Liver Tissue Using a Validated QuEChERS Extraction and LC-MS-MS Analysis.
Cox J; Train A; Field A; Ott C; DelTondo J; Kraner J; Bailey K; Gebhardt M; Arroyo-Mora LE
J Anal Toxicol; 2021 Jan; 44(9):957-967. PubMed ID: 32020181
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.
Feierman DE; Lasker JM
Drug Metab Dispos; 1996 Sep; 24(9):932-9. PubMed ID: 8886601
[TBL] [Abstract][Full Text] [Related]
15. Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).
Steuer AE; Williner E; Staeheli SN; Kraemer T
Drug Test Anal; 2017 Jul; 9(7):1085-1092. PubMed ID: 27736030
[TBL] [Abstract][Full Text] [Related]
16. Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine.
Gampfer TM; Wagmann L; Park YM; Cannaert A; Herrmann J; Fischmann S; Westphal F; Müller R; Stove CP; Meyer MR
Arch Toxicol; 2020 Jun; 94(6):2009-2025. PubMed ID: 32249346
[TBL] [Abstract][Full Text] [Related]
17. Zebrafish larvae: A new model to study behavioural effects and metabolism of fentanyl, in comparison to a traditional mice model.
Pesavento S; Bilel S; Murari M; Gottardo R; Arfè R; Tirri M; Panato A; Tagliaro F; Marti M
Med Sci Law; 2022 Jul; 62(3):188-198. PubMed ID: 35040690
[TBL] [Abstract][Full Text] [Related]
18. Identification of Unique Metabolites of the Designer Opioid Furanyl Fentanyl.
Goggin MM; Nguyen A; Janis GC
J Anal Toxicol; 2017 Jun; 41(5):367-375. PubMed ID: 28369517
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of 4F-MDMB-BICA in zebrafish by liquid chromatography-high resolution mass spectrometry.
Yue L; Xiang P; Shen B; Xu D; Song F; Yan H
Drug Test Anal; 2021 Jun; 13(6):1223-1229. PubMed ID: 33629502
[TBL] [Abstract][Full Text] [Related]
20. Fatality Following Ingestion of Tetrahydrofuranylfentanyl, U-49900 and Methoxy-Phencyclidine.
Krotulski AJ; Papsun DM; Friscia M; Swartz JL; Holsey BD; Logan BK
J Anal Toxicol; 2018 Apr; 42(3):e27-e32. PubMed ID: 29186585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
